Study on the Molecular Mechanism of Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome From CLCF1 Interventing on JAK-STAT Signaling Pathways
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- osteoporosis treatment within six months of study enrollment
研究概览
简要总结
This study use RT-PCR and Western Blot technique to detect the expression of CLCF1 mRNA and protein in POP Kidney Yin deficiency group and healthy group to verify the relevance between CLCF1 and POP the kidney Yin deficiency syndrome.Through siRNA and overexpression,observe the mRNA and protein 's expression of CBP、JAK1、STAT4 and the protein phosphorylation of JAK1、STAT4 in JAK-STAT signal to reveal the CLCF1 regulate the CBP's mechanism.Use the Liuwei Dihuang Pills to detect the effect of treatment ,compare use or not the Liuwei Dihuang Pills to detect the mRNA and protein 's expression of CLCF1、CBP etc.Aim to clarify the POP kidney Yin deficiency molecular mechanism.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 75 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •The Participants who volunteer to be test subjects, and can accept experimental drugs, and promise to finish the course should sign the informed consent.
- •Female ages 45 to 75 had gone through natural menopause before two years
- •In accordance with the western medicine diagnostic criteria of osteoporosis and belong to kidney Yin deficiency syndrome differentiation of traditional Chinese medicine certificate;
- •In accordance with the western medicine diagnostic criteria;
- •In accordance with TCM diagnostic methods; .If any of the above answers are no, The subjects couldn't in the study.
排除标准
- •Do not accord with standard of the western medicine diagnosis and TCM diagnostic methods
- •Age: <44 and > 76 years old;
- •With hyperparathyroidism, osteomalacia, rheumatoid arthritis, multiple myeloma and other serious complications such as secondary osteoporosis; Late or deformity, disability, loss of labor;
- •With cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious primary diseases;
- •Psychosis or alzheimer's patients;
- •Nearly three months, the use of hormone replacement therapy (HRT) and taking calcitonin, nearly six months has used double phosphonic acid salt for 15 days, etc.;
- •This medicine allergic constitution or composition of known to have allergies;
- •In a critical condition, It's difficult to make exact evaluators to efficacy and safety of the new drugs;
研究组 & 干预措施
Liuwei Dihuang Pills
干预措施: Liuwei Dihuang Pills (Drug)
结局指标
主要结局
osteoporosis treatment within six months of study enrollment
时间窗: Liuwei Dihuang Pills therapy (up to six months)
次要结局
未报告次要终点